In colorectal cancer cells, HSP90 inhibitor NVP-AUY922 can suppress the JAK2-STAT3-Mcl-1 signaling pathway to enhance TRAIL-induced apoptosis (Lee et al., 2015). Here, JAK2 is linked to colorectal cancer.